Literature DB >> 23955113

Meningeal myelomatosis developed after treatment with novel agents.

Mikiko Ise1, Chikara Sakai, Kyoya Kumagai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955113     DOI: 10.1007/s12185-013-1415-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

Authors:  Alessandro Gozzetti; Alfonso Cerase; Flavia Lotti; Davide Rossi; Antonio Palumbo; Maria Teresa Petrucci; Francesca Patriarca; Chiara Nozzoli; Michele Cavo; Massimo Offidani; Michele Floridia; Salvatore Berretta; Roberto Vallone; Pellegrino Musto; Francesco Lauria; Elena Marchini; Alberto Fabbri; Stefania Oliva; Elena Zamagni; Fabiana Gentillini Sapienza; Stelvio Ballanti; Giuseppe Mele; Monica Galli; Maria Teresa Pirrotta; Francesco Di Raimondo
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  Thalidomide for the treatment of leptomeningeal multiple myeloma.

Authors:  Hattori Yutaka; Yabe Mariko; Okamoto Shinichiro; Morita Kunihiko; Tanigawara Yusuke; Ikeda Yasuo
Journal:  Eur J Haematol       Date:  2006-04       Impact factor: 2.997

3.  Cerebrospinal fluid penetrance of lenalidomide in meningeal myeloma.

Authors:  Saiyed Anwer; Freya Collings; Kim Trace; Yongkai Sun; Alexander Sternberg
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

  3 in total
  1 in total

1.  Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review.

Authors:  Rui Bergantim; Juliana Bastos; Maria José Soares; Bruno Carvalho; Pedro Soares; Cristina Marques; Jennifer Costa; José Eduardo Guimarães; Fernanda Trigo
Journal:  Case Rep Hematol       Date:  2020-01-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.